Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer - Wikidata - awgldk - TriplyDB

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

http://www.wikidata.org/entity/Q28473944

about

The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer Projecting distribution of the overwintering population of Sogatella furcifera (Hemiptera: Delphacidae), in Yunnan, China with analysis on key influencing climatic factors.MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer.Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Prognostic value of miR-21 in various cancers: an updating meta-analysis.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.MicroRNAs: novel players in cancer diagnosis and therapies.MicroRNA expression and clinical outcome of small cell lung cancer MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis Critical role of laser microdissection for genetic, epigenetic and proteomic analyses in pancreatic cancer.Therapeutic options for the management of pancreatic cancer.MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer.Oocytes selected using BCB staining enhance nuclear reprogramming and the in vivo development of SCNT embryos in cattle.MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms.High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis.Shielding the messenger (RNA): microRNA-based anticancer therapies.Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals.MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma

P2860

Q26744298-DA548D85-31F7-4E5D-B745-072D8AC6527C Q26746000-38B0AAAD-9BA6-46B5-9B5C-1493BDCDB962 Q26765233-A174FDA8-63B5-43AC-A038-70699D0DF414 Q26769953-59F64891-F02F-4CD4-803D-2BCFB5F14EAC Q26774628-1161D201-A97B-402B-905B-E5E84DD7A6FC Q26774636-086367E1-BE4E-4A83-9BB5-4A6DF58C075A Q26778918-B4582A91-10AE-4D76-8F25-0C9662F348E9 Q26851333-9D73F8B6-5FD8-44B0-A9F8-741F0D4035A9 Q28066991-AEB206B9-9A0A-4F49-A512-939A55691188 Q28075540-6BF8BEDA-B5C2-4615-81F1-E540864B02A5 Q31009966-956C2717-DE49-4B6A-9532-4DFF5DBFCEA1 Q31132024-DC7EFE14-500D-4551-938A-A8EAB68E9951 Q33572313-8E7B0518-88AC-4AF6-9990-59967ABAAD3A Q33579721-BD51CA26-A7A8-4A71-95AA-114EE34045FC Q33668095-E8639F5D-3B39-419C-95E6-FD9FA52033BF Q33802900-75E2446F-EE12-4211-9B87-FF478D4E9A66 Q33862088-859324C8-C7E8-4F57-9E90-62282ED19C43 Q33899211-95D34C66-75BD-4A69-825A-B9F32C48F8B4 Q33911224-A1732878-4EE9-4467-B9D6-F03F25E933DA Q33914573-0EFF4DC6-53D0-4E22-ADB2-DEA2FECF8824 Q33952288-1C4184C6-3547-48BA-9EB4-4C357A9E799D Q34010854-5823512D-489D-40D1-90FA-5C2A5175272F Q34014091-00F3B9EB-152A-4CFF-9C42-3128FE3D4D41 Q34093776-1C0908EC-FCAA-4703-A7C0-87EF9108C4A6 Q34093798-C5D855E4-815A-4295-A64D-FE13390A28C7 Q34151444-DCBD0721-9538-4463-BBA8-391CE412330F Q34177065-D07B8E0F-13A3-4C95-9C09-4415BE153CBA Q34257267-3325DCC5-9617-4502-BE87-F16A2B2A26EF Q34268278-05A3A20F-E4B2-45D3-AF16-D188B6791FF2 Q34310243-0489CE21-A717-4AB1-A25E-9AB2C670584D Q34471577-F1BC46A2-A42E-4151-AFD5-159F1614579B Q34479270-C8F0283A-D6C5-41E4-8628-CE829473BD3C Q34513935-65A255FB-F502-4F23-B993-70EFE8A8C138 Q34775829-92D4A832-4736-4EA6-B89F-BB1FC3072DE3 Q35039281-169802E3-5C31-490C-AE32-F94F34B2E72C Q35050650-727E88A1-830D-4BC5-AC03-2342F40D5A1E Q35070602-82CA8448-D8A1-4D25-A046-9484B22B7986 Q35087659-EB5F7F9F-3CCD-430C-B152-0869049A570D Q35388050-E1305E26-2F66-45DE-84EC-E6C6E3AC2C9C Q35532069-CFD2E76C-C0EC-4511-BAC0-23B857D419D7

P2860

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

http://www.wikidata.org/entity/Q28473944

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Identification of microRNA-21 ...... n resectable pancreatic cancer

@ast

Identification of microRNA-21 ...... n resectable pancreatic cancer

@en

Identification of microRNA-21 ...... n resectable pancreatic cancer

@nl

type

label

Identification of microRNA-21 ...... n resectable pancreatic cancer

@ast

Identification of microRNA-21 ...... n resectable pancreatic cancer

@en

Identification of microRNA-21 ...... n resectable pancreatic cancer

@nl

prefLabel

Identification of microRNA-21 ...... n resectable pancreatic cancer

@ast

Identification of microRNA-21 ...... n resectable pancreatic cancer

@en

Identification of microRNA-21 ...... n resectable pancreatic cancer

@nl

P1433

Q28473944-6B9C139C-3E35-4696-B67A-2B8CF18BAFDC

P1476

Q28473944-8165712E-B7E5-4413-BEE0-73AC5493CF1E

P2093

Q28473944-0851C229-5D2C-4EEB-A2AE-B93D4DCB5C0D

Q28473944-5487C1EC-A700-4030-A138-58F301252D5A

Q28473944-7A9A3137-CAEC-4A5B-89F9-0CF441B28A7A

Q28473944-7DAF1085-96CA-43DB-8EAF-C2936977144E

Q28473944-90B2E06A-280B-4784-A436-759FAFE97D87

Q28473944-9A87897A-29FA-422C-A4B7-F3EE55874D5E

Q28473944-A0115634-EED6-4119-AB57-706B37B4004B

Q28473944-A3298F52-DDF4-40BF-B2A4-518A1DB0D2BD

Q28473944-CC369918-6BDE-4481-ADC9-B17BF37D1F47

Q28473944-ECFA2CA8-2E44-4C16-8661-F54C0EDA366A

P2860

Q28473944-02C7EFB5-100D-4101-9E0D-3D208E8642FB

Q28473944-050D7A0B-4DBE-40C1-8B48-1D94FFAA6990

Q28473944-06CD1548-E587-46C4-A167-8E1E4C7DAD4A

Q28473944-070C1CB0-461E-45A9-8256-FCD26FD6775B

Q28473944-077A9AF1-7DD4-4CB5-B496-0ECEE8ABA6FE

Q28473944-130792A9-031E-47FB-9387-E27E6D8CFB32

Q28473944-1880FBD0-0C3E-4910-B305-57E006C69D0A

Q28473944-195655CF-D185-43F8-A0AF-05ED463CDF47

Q28473944-1FEBE722-7006-4654-B19B-A61E2EBC7B02

Q28473944-2016669F-C841-4E0B-81FD-F92886F1DCA7

P304

Q28473944-B493085D-E81E-47BD-B7C9-01DB7FF08C7C

P31

Q28473944-4D35097B-D26C-4AB7-8671-3C79F2B4F3C6

P3181

Q28473944-071E1EAC-894A-40A4-BAF5-1F5259B269A1

P356

Q28473944-435B7995-5F38-40DF-ADF6-D4C25379FB39

P407

Q28473944-6B0160B0-78A6-4170-8990-C20CAA6A130B

P433

Q28473944-8CCD0CB4-DCA0-49FF-8A82-829A870337C8

P478

Q28473944-F9775899-6B02-4E0B-AD92-D05C6E2417F1

P50

Q28473944-84BD7224-47D7-457B-A17E-1952931D8E7B

Q28473944-A475F235-6231-4FB6-81FF-41AC80B4AC1C

Q28473944-B8439AA9-E398-4ACB-A838-656560B51A9A

Q28473944-C913AD89-74A6-4782-A08D-B75E07BAA123

P577

Q28473944-465F97DE-BE6A-4B97-A9D8-971808CFE613

P5875

Q28473944-D3A1D2D4-0D9F-40F4-BAB0-D86BD7877569

P698

Q28473944-F6BE1481-E8EB-4C16-BB5F-55B026FF1B55

P921

Q28473944-DB71EF82-4CB2-46F1-9FFF-00D94DF5BC81

Q28473944-E36ED56A-202E-4746-A422-973FBF52D5E3

P932

Q28473944-2BE2F281-574C-4351-B919-32F65D78C659

P3181

P356

JOURNAL.PONE.0010630

P1433

P1476

Identification of microRNA-21 ...... n resectable pancreatic cancer

@en

P2093

Godefridus J Peters

http://www.w3.org/2001/XMLSchema#string

Jin-Hyeok Hwang

http://www.w3.org/2001/XMLSchema#string

Johannes Voortman

http://www.w3.org/2001/XMLSchema#string

Joo Kyung Park

http://www.w3.org/2001/XMLSchema#string

Leticia G Leon

http://www.w3.org/2001/XMLSchema#string

Marco Del Chiaro

http://www.w3.org/2001/XMLSchema#string

Min A Kim

http://www.w3.org/2001/XMLSchema#string

Seth M Steinberg

http://www.w3.org/2001/XMLSchema#string

Sun-Whe Kim

http://www.w3.org/2001/XMLSchema#string

Yong-Tae Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Nonparametric Estimation from Incomplete Observations

MicroRNAs: small RNAs with a big role in gene regulation

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNA expression profiles classify human cancers

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

P304

e10630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

741691

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0010630

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Giaccone

Elisa Giovannetti

Gyeong Hoon Kang

P577

2010-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44626853

http://www.w3.org/2001/XMLSchema#string

P698

20498843

http://www.w3.org/2001/XMLSchema#string

P921

P932

2871055

http://www.w3.org/2001/XMLSchema#string